Clinical outcomes of capecitabine-based versus S-1-based regimens as first-line chemotherapy in patients with unresectable or metastatic gastric cancer: a propensity score matched single-center comparison

BACKGROUND: Fluoropyrimidine-based regimens are the cornerstone of first-line chemotherapy for metastatic gastric cancer (GC). Capecitabine or S-1 might be used as an alternative to infusional 5-fluorouracil, especially in pan-Asian. This study aimed to compare the clinical outcomes of capecitabine-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gastrointest Oncol
Autori principali: Wang, Jin, Li, Zhi, Qu, Jinglei, Song, Na, Chen, Ying, Cheng, Yu, Zhang, Simeng, Qu, Xiujuan, Liu, Yunpeng
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475324/
https://ncbi.nlm.nih.gov/pubmed/32953151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-52
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi